Table 3 Somato-sensoric and autonomic neuropathy in the groups from baseline and follow-up
DM + CF (n = 11) | DM − CF (n = 11) | p value | |
|---|---|---|---|
Mod.NSS, baseline | 2; 8 | 1; 6 | 0.946 |
Mod.NSS, follow-up | 4; 7 | 3; 9 | – |
p value | 0.250 | 0.557 | – |
DM + CF (n = 11) | DM − CF (n = 11) | p value+ | |||
|---|---|---|---|---|---|
Healthy foot | Charcot foot | Right foot | Left foot | ||
Biothesiometry, baseline (V) | 38 ± 15 | 40 ± 15 | 26 ± 11 | 24 ± 13 | 0.014* |
Biothesiometry, follow-up (V) | 38 ± 15 | 39 ± 15 | 40 ± 10 | 38 ± 10 | – |
Δfollow-up | − 1 ± 11 | − 1 ± 5 | 14 ± 13 | 14 ± 16 | 0.003* |
DM + CF (n = 11) | DM − CF (n = 6) | p value | |
|---|---|---|---|
Heart-rate variability, baseline (beats/min) | 9.7 ± 5.9 | 14.3 ± 7.5 | 0.127 |
Heart-rate variability, follow-up (beats/min) | 7.2 ± 4.0 | 12.6 ± 7.7 | – |
p value | 0.053 | 0.762 | – |
Δfollow-up | − 2.5 ± 3.7 | − 0.4 ± 3.2 | 0.274 |